Why current peptide-based cancer vaccines fail: lessons from the three Es-Reference-Cited by-同舟云学术

Why current peptide-based cancer vaccines fail: lessons from the three Es

Published:2009-07 Issue:4 Volume:1 Page:513-516
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Claesson Mogens H¹

Affiliation:

1. Department of International Health, Immunology & Microbiology, The Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt.09.35

Reference24 articles.

1. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

2. Clinical and Immunologic Responses to Active Specific Cancer Vaccines in Human Colorectal Cancer

3. LowyDR, Schiller JT: Preventive cancer vaccines. In:DeVita, Hellman and Rosenberg’s Cancer: Principles & Practice of Oncology.Vincent T, DeVita VT Jr, Hellman S, Rosenberg SA (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA,351–368 (2008).

4. Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma

5. Combination Therapy of Personalized Peptide Vaccination and Low-Dose Estramustine Phosphate for Metastatic Hormone Refractory Prostate Cancer Patients: An Analysis of Prognostic Factors in the Treatment

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines;Journal of Peptide Science;2024-04-03

2. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines;Biomaterials;2022-01

3. Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma;Frontiers in Oncology;2020-06-03

4. Breast cancer vaccines: Heeding the lessons of the past to guide a path forward;Cancer Treatment Reviews;2020-03

5. Biomaterials for vaccine-based cancer immunotherapy;Journal of Controlled Release;2018-12